American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Text/HTML

Recent AHPA Advocacy

EasyDNNNews

IADSA update on international supplement regulations

IADSA update on international supplement regulations

September 2020 IADSA Newsflash

In this issue of the IADSA Newsflash:  France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.

Supplement and Hemp Industry Associations Applaud Bipartisan Legislation to Regulate Hemp-Derived CBD

Bill directs FDA to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD

the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.
AHPA Hemp-CBD Supplement Virtual Congress

AHPA Hemp-CBD Supplement Virtual Congress

On-demand -- Recorded Aug. 27

AHPA's second, annual Hemp-CBD Supplement Congress was presented on August 27, 2020 and provides companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. This event delivers the latest information to you on-demand.

AHPA joins request to give small firms more time to meet new FDA food labeling rules

AHPA urges FDA to extend enforcement discretion to small firms

AHPA joined 16 other trade associations in a Aug. 21 letter to the Food and Drug Administration (FDA) to request more time for small businesses to understand and comply with the Agency’s new, wide-ranging nutrition labeling regulations.
IADSA update on international supplement regulations

IADSA update on international supplement regulations

July 2020 IADSA Newsflash

This issue of the IADSA Newsflash covers Australia TGA reclassifies certain sports supplements to be regulated as medicines, South Africa down scheduled CBD to a category of complementary medicine, Korea has updated its functional food code to include ginseng as helpful to bone health and the European Commission (EC) acknowledges the potential to consider traditional use of botanicals in the efficacy assessment of health claims when traditional medicine products exist for botanicals used in foods.

AHPA requests USDA APHIS amend and delay Phase VI of the import declarations enforcement schedule

“Other” essential oils should be removed from the list of products covered under Phase VI

In comments submitted to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), AHPA requests the agency to amend Phase VI of its import declarations enforcement schedule by removing “other” essential oils from the list of products covered under this phase.

AHPA requests adequate federal funding for USPS

AHPA members depend on the Postal Service to transport herbal products

AHPA President Michael McGuffin sent a letter to Congressional leaders in the U.S. House and Senate to request adequate federal funding be included in a fourth COVID-19 relief package to ensure the financial viability and continued operations of the United States Postal Service (USPS).

FDA and FTC highlight attention to intravenous therapies and social media in COVID-19 warning letters

Excerpt from the June 2020 AHPA Report

Since the first week of March, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have been issuing warning letters alleging that marketers promoted a wide variety of products with claims to prevent, treat, mitigate, diagnose or cure COVID-19. AHPA has analyzed 135 COVID-19 related warning letters issued by either FDA or FTC or by the agencies jointly between March 6, 2020, and May 11, 2020, and made available in each agency’s coronavirus information center as of May 15, 2020.

Request for proposals: Slippery elm sustainable wild harvest study

Request for proposals: Slippery elm sustainable wild harvest study

Deadline extended to July 10, 2020

The AHPA Foundation for Education and Research on Botanicals (AHPA ERB Foundation) is issuing a request for proposals to award grant funding to eligible applicants in order to enhance and promote knowledge and understanding of sustainable harvest of slippery elm (Ulmus rubra).  The grant supports research effects of varying rates of wild slippery elm bark harvest on tree population health and recovery across multiple harvest sites in order to inform sustainable harvest and management decisions for the species. The anticipated amount of funding available for a sustainable wild slippery elm bark harvest research project is up to $10,000 annually for up to 5 years.

AHPA Hemp-CBD Status Report

Updated in April 2020 to cover recent FDA and USDA actions

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).
RSS
12345678910 Last

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.